He Jianyu
-
106
-
-
-
- Director of Minimally Invasive Center
- Specialty: He is proficient in applying chemotherapy, targeted therapy, immunotherapy and monoclonal antibodies therapy to treating various malignant tumors, including liver cancer, breast cancer, lung cancer, gastro-intestinal cancer, esophageal cancer, nasoph
| Introduction:
Oncologist, chief physician, a postdoctoral researcher of Imperial College London, with a doctorate from Shanghai Medical College Fudan University.
| Specialty:
He is proficient in applying chemotherapy, targeted therapy, immunotherapy and monoclonal antibodies therapy to treating various malignant tumors, including liver cancer, breast cancer, lung cancer, gastro-intestinal cancer, esophageal cancer, nasoph
| Medical Experience:
He is a member of many academic associations in China. Having engaged in clinical oncology and researches in 3A hospitals for over 30 years, he is proficient in applying chemotherapy, targeted therapy, immunotherapy and monoclonal antibodies therapy to treating various malignant tumors, including liver cancer, breast cancer, lung cancer, gastro-intestinal cancer, esophageal cancer, nasopharyngeal cancer and so on, especially good at treating different advanced and metastatic solid tumors with ablation, radiofrequency to thyroid mass, minimally invasive therapy (radioactive I125 seed implantation, intervention surgery) and performing pathology biopsy of various solid tumors. He is also skilled in seed implantation surgery for various tumors and metastases, microwave and radiofrequency ablation surgery, pathology biopsy for solid tumors, gaining rich experience in minimally invasive surgeries for neck and bone metastatic tumors.
| Research Technology:
Molecular biology, pathophysiology, diagnosis and standardized treatment, and minimally invasive treatment for recurrence and metastases of malignant tumors.
The Multidisciplinary Team
-
![Cui Jianguo]()
- Cui Jianguo
- Chief Physician Director
- Specialty: Having engaging in the clinical diagnosis and treatment for more than 30 years, he excels in treating various solid tumors, including nasopharyngeal cancer, laryngeal cancer, lung cancer, esophageal cancer, stomach cancer, liver cancer, bile duct can
-
Reserve
-
![He Jianyu]()
- He Jianyu
- Chief Physician Director of Minimally Invasive Center
- Specialty: He is proficient in applying chemotherapy, targeted therapy, immunotherapy and monoclonal antibodies therapy to treating various malignant tumors, including liver cancer, breast cancer, lung cancer, gastro-intestinal cancer, esophageal cancer, nasoph
-
Reserve
-
![Xiang Qide]()
- Xiang Qide
- Chief Physician Director
- Specialty: He is specialized in combination therapy including chemotherapy, targeted therapy, immunotherapy and other treatments for lung cancer, breast cancer, colorectal cancer, liver cancer, stomach cancer, esophageal cancer, lymphoma, head and neck cancer.
-
Reserve
-
![Pu Ruilian]()
- Pu Ruilian
- Attending Physician Director of Ultrasound Department
- Specialty: Specialized in ultrasound diagnosis of solid tumors (breast, liver, kidney, gynecology, head and neck tumors, etc.).
-
Reserve
-
![AGILA ADNAN]()
- AGILA ADNAN
- Resident Physician International Oncology Resident
- Specialty: Specialized in chemotherapy, targeted therapy, and various comprehensive treatment measures and individualized treatment of breast cancer, lung cancer, gastrointestinal tumors, head and neck tumors, gynecological tumors, common chronic diseases in in
-
Reserve
-
![Ban Zhonghua]()
- Ban Zhonghua
- Attending Physician Director of Interventional Radiology
- Specialty: Specialized in medical imaging diagnosis of solid tumors (breast, liver, kidney, gynecology, head and neck tumors, etc.), systemic tumor vascular interventional treatment, and various stent placement procedures.
-
Reserve
